The four new patents granted to Lexaria Bioscience Corp. directly relate to its DehydraTECH technology, which is a key aspect of the company's product offerings. This strengthens its intellectual property portfolio and could potentially increase the value of the technology, leading to a positive short-term impact on the company's stock price.